Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2009
10/22/2009US20090263863 Modification of protein glycosylation in methylotrophic yeast
10/22/2009US20090263852 Nonapoptotic forms of cell death and methods of modulation
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263829 Alzheimer's disease biomarkers and methods of use
10/22/2009US20090263785 Modified HIV-1 Peptides and Use Thereof in the Detection of Anit-HIV Antibodies
10/22/2009US20090263783 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
10/22/2009US20090263452 Drug-eluting intravascular prostheses and methods of use
10/22/2009US20090263425 Methods of stimulating an immune response against prostate specific antigen
10/22/2009US20090263424 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/22/2009US20090263420 Virus-Like Particles As Vaccines For Paramyxovirus
10/22/2009US20090263414 Bifunctional Protein Anchors
10/22/2009US20090263412 Non-Splicing Variants of gp350/220
10/22/2009US20090263411 Compositions, splice variants and methods relating to ovarian specific genes and proteins
10/22/2009US20090263409 Cancer antigen peptide formulations
10/22/2009US20090263406 JY-1 Regulation Of Granulosa Cell Function And Early Embryonic Development In Cattle
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263394 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
10/22/2009US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection
10/22/2009US20090263388 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
10/22/2009US20090263376 Breaking immunological toterance with a genetically encoded unnatural amino acid
10/22/2009US20090263373 Non-neurotoxic plasminogen activating factors for treating of stroke
10/22/2009US20090263355 Deamidated interferon-beta
10/22/2009US20090263352 Methods for treating viral infection using il-28 and il-29 cysteine mutants
10/22/2009US20090263348 Nucleic Acids Encoding Multimeric Fusion Proteins of TNF Superfamily Ligands
10/22/2009US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009US20090263318 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
10/22/2009CA2725257A1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation
10/22/2009CA2721635A1 Compositions comprising halorhodopsin
10/22/2009CA2721470A1 Somatostatin receptor 2 antagonists
10/22/2009CA2721360A1 Methods and compositions for treating and identifying compounds to treat age-related macular degeneration
10/22/2009CA2721333A1 Novel lipid formulations for nucleic acid delivery
10/22/2009CA2721246A1 Deletion mutants of flagellin and methods of use
10/22/2009CA2721169A1 Prostate specific membrane antigen antibodies and antigen binding fragments
10/22/2009CA2721156A1 Stable amyloid beta monomers and oligomers
10/22/2009CA2721108A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same
10/22/2009CA2721032A1 Anti-areg/hb-egf antibodies and treatment
10/22/2009CA2721019A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
10/22/2009CA2720980A1 Methods for enhanced production of bone morphogenetic proteins
10/22/2009CA2720652A1 Functional enhancement of yeast to minimize production of ethyl carbamate via modified transporter expression
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP2110436A1 Polypeptides having neutrophil stimulating activity
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110433A1 Method of separating and distinguishing walnut from pecan nut
10/21/2009EP2110385A1 Stabilized factor VIII with engineered disulfide bonds
10/21/2009EP2110384A1 Hepatopoietin and use thereof
10/21/2009EP2110383A1 Hypoallergenic variants
10/21/2009EP2110382A1 Infectious cDNA of an improved vaccine strain of measles virus, use for immunogenic compositions
10/21/2009EP2110381A1 Long lasting fusion peptide inhibitors of viral infection
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2109673A2 Methods and compositions for enhanced protein expression and purification
10/21/2009EP2109621A2 Factor h polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
10/21/2009EP2109620A1 Interleukin-21 variants with altered binding to the il-21 receptor
10/21/2009EP2109619A2 Modifications of peptide compositions to increase stability and delivery efficiency
10/21/2009EP2109457A1 Therapeutic application of kazal-type serine protease inhibitors
10/21/2009EP2109456A2 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions
10/21/2009EP1761553B1 Tumor-associated peptides that bind to mhc-molecules
10/21/2009EP1716176B1 Cd38 splice variant and uses thereof
10/21/2009EP1697412B1 Method for purifying fsh
10/21/2009EP1660528B1 Muteins of tear lipocalin
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009EP1648521B1 Compositions and methods for treating cardiac dysfunction
10/21/2009EP1516050B1 Generation of plants with improved pathogen resistance
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009EP1408736B1 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
10/21/2009EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/21/2009EP1371373B1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/21/2009EP1047784B1 Neissera meningitidis antigens
10/21/2009EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009CN101563456A Artificial binding proteins based on a modified alpha helical region of ubiquitin
10/21/2009CN101563454A Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma
10/21/2009CN101563364A Insulinotropic peptide synthesis
10/21/2009CN101563363A Targeting complement factor H for treatment of diseases
10/21/2009CN101563362A Recombinant HCV E2 glycoprotein
10/21/2009CN101563361A Influenza viruses able to infect canids, uses thereof
10/21/2009CN101563360A Peptide-cytotoxic conjugates
10/21/2009CN101563103A Novel nematode protein and its use in producing anthelminthic agents and vaccines
10/21/2009CN101563098A IL-17A/F heterologous polypeptides and therapeutic uses thereof
10/21/2009CN101563096A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
10/21/2009CN101563091A Composition comprising crustacean gastrolith components and its use
10/21/2009CN101560522A Method for expressing IBV-HN99 membrane protein gene in insect-rhabdovirus system
10/21/2009CN101560518A Membrane protein gene of chicken infective bronchitis virus and clone method thereof
10/21/2009CN101560499A Novel targets for herbicides and transgenic plants resistant to said herbicides
10/21/2009CN101560254A Enrichment and separation method of blue green algae phycocyanin
10/21/2009CN101560253A Method for the crystallization of human serum albumin
10/21/2009CN101560252A Method for extracting zein by microwave
10/21/2009CN101560251A Associated protein for plant root growth and encoding gene and application thereof
10/21/2009CN101560250A Extracting method of natural pigment glycosidoprotein in eucheuma
10/21/2009CN101560249A Amino acid sequence, gene sequence and expression vector of heat shock protein HmHSP 70 of hypsizygus marmoreus
10/21/2009CN101560248A Attenuated enterotoxin C2 superantigen mutant protein, preparation method and application thereof
10/21/2009CN101560247A Mucous membrane immunologic adjuvant using heat-sensitive colitoxin dual-mutant as vaccine
10/21/2009CN101560243A Method for separating and purifying abrin and product thereof
10/21/2009CN100552027C Gene families associated with cancers
10/21/2009CN100551931C T cell receptor display
10/20/2009US7606670 Comprises ribosomal protein for use as model in the rational design and modeling of drugs; antibiotic preparation; high resolution crystal structure
10/20/2009US7606401 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse
1 ... 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 ... 2916